Post-approval studies (Phase 4)Study completedNCT00922207
What this trial is testing
PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 280